Joseph Guydish1, Emma Passalacqua1, Anna Pagano1, Cristina Martínez2, Thao Le1, JongSerl Chun3, Barbara Tajima1, Lindsay Docto1, Daria Garina1, Kevin Delucchi4. 1. University of California, San Francisco, Philip R. Lee Institute for Health Policy Studies, San Francisco, CA, USA. 2. Tobacco Control Unit, Cancer Prevention and Control Department, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, Barcelona, Spain. 3. Department of Social Welfare, Ewha Womans University, Seoul, South Korea. 4. Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA.
Abstract
AIMS: Smoking prevalence is higher among people enrolled in addiction treatment compared with the general population, and very high rates of smoking are associated with opiate drug use and receipt of opiate replacement therapy (ORT). We assessed whether these findings are observed internationally. METHODS: PubMed, PsycINFO and the Alcohol and Alcohol Problems Science Database were searched for papers reporting smoking prevalence among addiction treatment samples, published in English, from 1987 to 2013. Search terms included tobacco use, cessation and substance use disorders using and/or Boolean connectors. For 4549 papers identified, abstracts were reviewed by multiple raters; 239 abstracts met inclusion criteria and these full papers were reviewed for exclusion. Fifty-four studies, collectively comprising 37,364 participants, were included. For each paper we extracted country, author, year, sample size and gender, treatment modality, primary drug treated and smoking prevalence. RESULTS: The random-effect pooled estimate of smoking across people in addiction treatment was 84% [confidence interval (CI) = 79, 88%], while the pooled estimate of smoking prevalence across matched population samples was 31% (CI = 29, 33%). The difference in the pooled estimates was 52% (CI = 48%, 57%, P < .0001). Smoking rates were higher in programs treating opiate use compared with alcohol use [odds ratio (OR) = 2.52, CI = 2.00, 3.17], and higher in ORT compared to out-patient programs (OR = 1.42, CI = 1.19, 1.68). CONCLUSIONS: Smoking rates among people in addiction treatment are more than double those of people with similar demographic characteristics. Smoking rates are also higher in people being treated for opiate dependence compared with people being treated for alcohol use disorder.
AIMS: Smoking prevalence is higher among people enrolled in addiction treatment compared with the general population, and very high rates of smoking are associated with opiate drug use and receipt of opiate replacement therapy (ORT). We assessed whether these findings are observed internationally. METHODS: PubMed, PsycINFO and the Alcohol and Alcohol Problems Science Database were searched for papers reporting smoking prevalence among addiction treatment samples, published in English, from 1987 to 2013. Search terms included tobacco use, cessation and substance use disorders using and/or Boolean connectors. For 4549 papers identified, abstracts were reviewed by multiple raters; 239 abstracts met inclusion criteria and these full papers were reviewed for exclusion. Fifty-four studies, collectively comprising 37,364 participants, were included. For each paper we extracted country, author, year, sample size and gender, treatment modality, primary drug treated and smoking prevalence. RESULTS: The random-effect pooled estimate of smoking across people in addiction treatment was 84% [confidence interval (CI) = 79, 88%], while the pooled estimate of smoking prevalence across matched population samples was 31% (CI = 29, 33%). The difference in the pooled estimates was 52% (CI = 48%, 57%, P < .0001). Smoking rates were higher in programs treating opiate use compared with alcohol use [odds ratio (OR) = 2.52, CI = 2.00, 3.17], and higher in ORT compared to out-patient programs (OR = 1.42, CI = 1.19, 1.68). CONCLUSIONS: Smoking rates among people in addiction treatment are more than double those of people with similar demographic characteristics. Smoking rates are also higher in people being treated for opiate dependence compared with people being treated for alcohol use disorder.
Authors: José Pérez de Los Cobos; Núria Siñol; Carmen Puerta; Vanessa Cantillano; Cristina López Zurita; Joan Trujols Journal: Psychiatry Res Date: 2010-05-26 Impact factor: 3.222
Authors: Martin D Ohlmeier; Karsten Peters; Andreas Kordon; Jürgen Seifert; Bert Te Wildt; Birgitt Wiese; Marc Ziegenbein; Hinderk M Emrich; Udo Schneider Journal: Alcohol Alcohol Date: 2007-08-31 Impact factor: 2.826
Authors: Gary A Giovino; Sara A Mirza; Jonathan M Samet; Prakash C Gupta; Martin J Jarvis; Neeraj Bhala; Richard Peto; Witold Zatonski; Jason Hsia; Jeremy Morton; Krishna M Palipudi; Samira Asma Journal: Lancet Date: 2012-08-18 Impact factor: 79.321
Authors: Erin A McClure; Nathaniel L Baker; Susan C Sonne; Udi E Ghitza; Rachel L Tomko; LaTrice Montgomery; Shanna Babalonis; Garth E Terry; Kevin M Gray Journal: Drug Alcohol Depend Date: 2018-08-25 Impact factor: 4.492
Authors: Joanna M Streck; Susan Regan; Yuchiao Chang; Jennifer H K Kelley; Daniel E Singer; Nancy A Rigotti Journal: Drug Alcohol Depend Date: 2017-07-08 Impact factor: 4.492
Authors: Joanna M Streck; Stacey C Sigmon; Jeffrey Priest; Cecilia L Bergeria; Danielle R Davis; John R Hughes; Andrea C Villanti; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Stephen T Higgins Journal: Exp Clin Psychopharmacol Date: 2020-02-06 Impact factor: 3.157
Authors: Alba González-Roz; Roberto Secades-Villa; Gema Aonso-Diego; Sara Weidberg; José R Fernández-Hermida Journal: Psychopharmacology (Berl) Date: 2021-05-24 Impact factor: 4.530
Authors: Yukai Zou; Donna E Murray; Timothy C Durazzo; Thomas P Schmidt; Troy A Murray; Dieter J Meyerhoff Journal: Psychiatry Res Neuroimaging Date: 2018-09-18 Impact factor: 2.376
Authors: Joseph Guydish; Barbara Tajima; Sowmya Pramod; Thao Le; Noah R Gubner; Barbara Campbell; Paul Roman Journal: Drug Alcohol Depend Date: 2016-07-14 Impact factor: 4.492